EMANUEL HUSU to Drug Evaluation, Preclinical
This is a "connection" page, showing publications EMANUEL HUSU has written about Drug Evaluation, Preclinical.
Connection Strength
0.021
-
Dual targeting of the PI3K/Akt/mTOR pathway as an antitumor strategy in Waldenstrom macroglobulinemia. Blood. 2010 Jan 21; 115(3):559-69.
Score: 0.021